CellSource First Quarter 2025 Earnings: JP¥2.27 loss per share (vs JP¥7.23 profit in 1Q 2024)

Simply Wall St · 03/12 21:32

CellSource (TSE:4880) First Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥849.0m (down 28% from 1Q 2024).
  • Net loss: JP¥45.0m (down by 132% from JP¥143.0m profit in 1Q 2024).
  • JP¥2.27 loss per share (down from JP¥7.23 profit in 1Q 2024).
earnings-and-revenue-growth
TSE:4880 Earnings and Revenue Growth March 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

CellSource Earnings Insights

Looking ahead, revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Life Sciences industry in Asia.

Performance of the market in Japan.

The company's shares are up 4.5% from a week ago.

Risk Analysis

Before you take the next step you should know about the 3 warning signs for CellSource that we have uncovered.